Clinical trial

Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.

NCT05379608

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-12-10

PhaseNA

Study timeline

Study start (actual)2021-12-10Date precision: day

Registry last updated2025-07-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COVID-19unresolved

Chronic Heart Failureunresolved

Hypertensionunresolved

Arrhythmiaunresolved

Conduct Disorderunresolved

Chronic Coronary Syndromeunresolved

Endothelial Dysfunctionunresolved

Diastolic Dysfunctionunresolved

Oxygen Consumptionunresolved

Quality of Lifeunresolved

Exercise Toleranceunresolved

Interventions

Intermittent hypoxic-hyperoxic trainingPROCEDURE

Intermittent hypoxic-hyperoxic training/controlPROCEDURE

Sponsors & collaborators

I.M. Sechenov First Moscow State Medical Universitylead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05379608 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.